Navigation Links
Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
Date:10/24/2008

ESSEX, United Kingdom, Oct. 24 /PRNewswire-FirstCall/ -- Minster Pharmaceuticals plc (AIM: MPM), the drug development company specializing in neurological and psychiatric disorders, is pleased to announce positive results from its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura. The median number of aura attacks was reduced by 68% (p=0.01) in patients receiving tonabersat when compared with placebo. This result in the primary endpoint of the study is both clinically and statistically highly significant.

A further primary endpoint showed a reduction in the number of migraine headache days. This reduction did not reach statistical significance, probably owing to the small number of patients participating in the trial and, it is thought, because some of the patients suffered a type of migraine aura that is not followed by headache.

The results also showed statistically significant effects on some of the secondary endpoints including the number of attacks of migraine headache and the number of auras followed by any headache. All secondary endpoints were numerically in favor of tonabersat compared with placebo.

Migraine with aura affects around 30 percent of migraine sufferers and is a type of migraine in which the headache is preceded by symptoms such as visual disturbances and abnormalities of speech and hearing. These aura symptoms are generally recognized as being difficult to treat with existing medications.

A total of 31 patients completed the Phase II trial, which was conducted at the Danish Headache Center at Copenhagen's Glostrup University Hospital. The principal investigator in the trial was Professor Jes Olesen, the Danish Headache Center's Director and one of the world's leading authorities on headache.

Under the trial's cross-over design, patients took either tonabersat or placebo once a day for a three-month period after which the treatment regimen was reversed such that those initia
'/>"/>

SOURCE Minster Pharmaceuticals plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
2. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
3. Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
4. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
5. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
6. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
7. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
8. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
9. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
10. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
11. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  TNI BioTech, Inc. ... company focused on the development, marketing and distribution ... filed definitive proxy materials with the Securities and ... Meeting of Shareholders to be held on Thursday, ... Time. The record date for determining those shareholders ...
(Date:7/28/2014)... ANGELES , SINGAPORE, and TOKYO , ... announced that it has appointed Roger Crystal , ... most recently served in the Global Business Development Product ... "Roger,s experience in developing business strategy and ... valuable as we continue to partner with biotechnology and ...
(Date:7/28/2014)... 28, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... its second quarter 2014 financial results for the period ended ... close. PDL,s management will host a conference call and webcast ... financial results.  A slide presentation relating to the call will ... Conference Call Details To access the live ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2
... SYDNEY, Australia, June 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis,(ASX: PXS; ... Limited to,manage and provide eligible patients worldwide with ... The program will allow patients who are unable ... are considered by their physician,to be suffering from ...
... Claims Cover Anti-Viral Applications of Novel Targeted Agents Under ... Company,s Anti-Phospholipid Technology Platform -, - Anti-Viral ... Presented at American Association of Immunologists Annual Meeting ... (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company developing ...
Cached Medicine Technology:Pharmaxis Establishes Named Patient Program for Bronchitol 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 4
(Date:7/28/2014)... A lush green lawn offers the perfect ... However, the summer heat, lack of rain, foot traffic, and ... and unhealthy. The Grounds Guys recommends these suggestions for nurturing ... once a week and set the height on the lawn ... grass roots from heat and allows roots to retain water ...
(Date:7/28/2014)... 28, 2014 An estimated 68,000 women ... metastatic breast and prostate cancers – an aggressive form ... spread to other parts of the body, such as ... Drexel University College of Medicine have developed ... inhibits metastatic progression by blocking tumor cells from β€œre-seeding.” ...
(Date:7/28/2014)... 28, 2014 Ticket Down is ... tickets in Dallas, TX at the Cotton Bowl. The ... the USA and it is an eight team tourney. ... world including teams from La Liga, Serie A, English Premier ... battle it out on the pitch include: Manchester United, ...
(Date:7/28/2014)... 2014 Ticket Down is a ... in Miami, FL at the Sun Life Stadium in early ... between Argentina and Brazil has is one that has continues ... rivalries are forming on a consistent basis. The rivalry ... height in the recent 2014 World Cup. To the ...
(Date:7/28/2014)... Steven Reinberg HealthDay ... People who have dementia and heart rhythm irregularities are more ... research has found. In fact, the study of more ... to 80 percent more likely to get a pacemaker than ... from this study is why folks with dementia are so ...
Breaking Medicine News(10 mins):Health News:Nurturing Lawns in the Summer Heat: The Grounds Guys® Offers Tips on Caring for Lawns This Summer 2Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 2Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3
... Deficit Hyperactivity Disorder (ADHD) is a prevailing issue in ... every year. A new study reveals that Pycnogenol, (pic-noj-en-all), ... French maritime pine tree, reduces ADHD in children. The ... and dopamine, resulting in a decrease of ADHD. ...
... NSERC Idea to Innovations grant and an Ontario Early ... and Nanosystems Laboratory ( http://amnl.mie.utoronto.ca ) at the University ... technology for automated microinjection of zebrafish embryos. , ... microrobotic system is capable of immobilizing a large number ...
... (Sept. 12, 2007) For the first time in ... ocean corals in its annual report of wildlife going ... by Conservation International (CI) and implemented jointly with the ... Charles Darwin Research Station and other regional institutions to ...
... helps teens make better food choices as adults, study finds ... dinner with their families on a regular basis are also ... a new study shows. , These teens also go on ... , Reporting in the Journal of the American Dietetic ...
... Medical,Technologies, Inc. today reported to its board of ... to include England, Canada, New,Zealand and Australia. ... began to come in as a result of ... the ReBuilder System(R). Through,word of mouth and the ...
... may be the last taboo,in our society, a subject that ... to fear -- to be avoided no matter what the ... "Triumph" is the result of daily writing over the ... about Darlyne,s,impending death and Philip,s loss. They have written this ...
Cached Medicine News:Health News:New study: Pine bark extract reduces ADHD symptoms in children 2Health News:Corals added to IUCN Red List of Threatened Species for first time 2Health News:Corals added to IUCN Red List of Threatened Species for first time 3Health News:ReBuilder Medical Technologies, Inc. Reports International Sales Expansion 2Health News:ReBuilder Medical Technologies, Inc. Reports International Sales Expansion 3Health News:ReBuilder Medical Technologies, Inc. Reports International Sales Expansion 4Health News:'Triumph' -- Traveling Towards Death: Preparing for a New Life 2
... , Combined Advanced Technologies, The ... technologically advanced combination of high pressure ... Proprietary coextrusion process yields a remarkably ... conventional high pressure balloon materials., Non-Compliant ...
Used retrograde to dilate the ureter and establish a conduit for a flexible ureteroscope. Supplied sterile in peel-open packages. Intended for one-time use....
... Diameter; 5.4 Fr Straight Channel; 33 or ... MRO-7 Integral Operating Ureteroscopes offer a small ... easy access to the ureter for diagnosis ... Fr) is ideal for large operating instruments, ...
... self-dilating, semi-rigid autoclavable operating ureteroscope featuring distortion-free ... for an enhanced, clear image. The universal ... diopters. The direction of view is 5 ... straight access operating channel is ideal for ...
Medicine Products: